State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases.

Autor: Van Linthout S; Berlin Institute of Health (BIH) at Charité - Universitätmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany.; German Center for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany., Stellos K; Department of Cardiovascular Research, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Heidelberg University, Mannheim, Germany.; German Centre for Cardiovascular Research (DZHK), partner site Heidelberg/Mannheim, Mannheim, Germany.; Helmholtz Institute for Translational AngioCardioScience (HI-TAC), Mannheim, Germany.; Biosciences Institute, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Newcastle, UK., Giacca M; School of Cardiovascular and Metabolic Medicine & Sciences and British Heart Foundation Centre of Research Excellence, King's College London, London, UK; Department of Medical Sciences, University of Trieste, Trieste, Italy., Bertero E; Cardiovascular Unit, Department of Internal Medicine, University of Genova, Genova, Italy., Cannata A; School of Cardiovascular and Metabolic Medicine & Sciences and British Heart Foundation Centre of Research Excellence, King's College London, London, UK., Carrier L; Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany., Garcia-Pavia P; Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, CIBERCV, Madrid, Spain.; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Universidad Francisco de Vitoria (UFV), Madrid, Spain., Ghigo A; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone,' University of Torino, Torino, Italy., González A; Program of Cardiovascular Diseases, CIMA and Department of Pathology, Anatomy and Physiology, Universidad de Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; CIBERCV (Network for Biomedical Research in Cardiovascular Disease), Instituto de Salud Carlos II, Madrid, Spain., Haugaa KH; ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Imazio M; Department of Medicine (DMED), University of Udine, and Cardiothoracic Department ASUFC, University Hospital Santa Maria della Misericordia, Udine, Italy., Lopes LR; Institute of Cardiovascular Science, University College London, London, UK.; Barts Heart Centre, St Bartholomew's Hospital, London, UK., Most P; Department of Cardiology, Angiology, Pulmonology, University Hospital Heidelberg, Heidelberg, Germany., Pollesello P; Content and Communication, Branded Products, Espoo, Finland., Schunkert H; Department of Cardiology, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany., Streckfuss-Bömeke K; Clinic for Cardiology and Pneumology, University Medical Center, Göttingen, Germany.; German Center for Cardiovascular Research (DZHK), Partner site Göttingen, Göttingen, Germany.; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.; Department of Translational Research, Comprehensive Heart Failure Center (CHFC), University Clinic Würzburg, Würzburg, Germany., Thum T; Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany., Tocchetti CG; Department of Translational Medical Sciences; Center for Basic and Clinical Immunology Research (CISI); Interdepartmental Center for Clinical and Translational Research (CIRCET); Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, Italy., Tschöpe C; Berlin Institute of Health (BIH) at Charité - Universitätmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany.; German Center for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany.; Deutsches Herzzentrum der Charité (DHZC), Department of Cardiology, Angiology and Intensive Medicine, Campus Virchow Klinikum, Berlin, Germany., van der Meer P; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van Rooij E; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands., Metra M; Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy., Rosano GMC; Cardiovascular Clinical Academic Group, St. George's University Hospitals, NHS Trust, University of London, London, UK.; Cardiology, San Raffaele Cassino Hospital, Cassino, Italy.; Department of Human Sciences and Promotion of Quality of Life, San Raffaele University of Rome, Rome, Italy., Heymans S; Centre for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium.; Department of Cardiology, Maastricht University, CARIM School for Cardiovascular Diseases, Maastricht, The Netherlands.; European Reference Network for Rare Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), Amsterdam, The Netherlands.

Publikováno v: European journal of heart failure [Eur J Heart Fail] 2024 Nov 22. Date of Electronic Publication: 2024 Nov 22.

ATF3's shielding hand to counter ischemia-reperfusion injury in cardiac macrophages.

Autor: Koopmans T; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, Netherlands., Cardona-Monzonís A; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, Netherlands., van Rooij E; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, Netherlands. e.vanrooij@hubrecht.eu.; Department of Cardiology, University Medical Center Utrecht, Utrecht, Netherlands. e.vanrooij@hubrecht.eu.

Publikováno v: Nature cardiovascular research [Nat Cardiovasc Res] 2024 Jan; Vol. 3 (1), pp. 15-17.

Dr Jyoti Patel, ESC Scientist of Tomorrow, interviews Dr Eva Van Rooij.

Autor: Patel J; University of Oxford, Oxford, UK., van Rooij E; Department of Cardiology, University Medical Centre, Utrecht, The Netherlands.

Publikováno v: Cardiovascular research [Cardiovasc Res] 2018 Mar 01; Vol. 114 (3), pp. e23-e24.

Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice.

Autor: Gladka MM; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands., Johansen AKZ; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands., van Kampen SJ; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands., Peters MMC; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands.; Department of Cardiology, Regenerative Medicine Center Utrecht, University Medical Center Utrecht, The Netherlands., Molenaar B; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands., Versteeg D; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands., Kooijman L; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands., Zentilin L; AAV Vector Unit, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy., Giacca M; School of Cardiovascular Medicine and Science, King's College London, London, United Kingdom., van Rooij E; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, The Netherlands.; Department of Cardiology, Regenerative Medicine Center Utrecht, University Medical Center Utrecht, The Netherlands.

Publikováno v: Cardiovascular research [Cardiovasc Res] 2023 May 02; Vol. 119 (3), pp. 802-812.

[Cardiomyopathy due to a mutation in the phospholamban gene: a high-impact genetic abnormality].

Autor: van der Meer P; UMCG, afd. Cardiologie, Groningen., van Rooij E; UMCU, afd. Cardiologie, Utrecht., Doevendans PA; UMCU, afd. Cardiologie, Utrecht.; Contact: Pieter A. Doevendans (p.doevendans@umcutrecht.nl).

Publikováno v: Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2023 Apr 19; Vol. 167. Date of Electronic Publication: 2023 Apr 19.